Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
A study published in Nature revealed that improving the gut microbiota could be a potential target in addressing Autism Spectrum Disorder (ASD). While it is known that the gut microbiota impacts health in many ways, it seems that modulating gut bacteria may also help to mitigate autism symptoms.
In this study, the researchers re-evaluated a small group of 18 ASD children who had severe digestive issues. Two years prior, these children underwent Microbiota Transfer Therapy (MTT), which consisted of antibiotics, cleansing the bowels, suppressing stomach acid and a fecal microbiota transplant. At the time of the MTT, the results showed significant increases in bacterial diversity along with marked improvements in both gastrointestinal (GI) and ASD symptoms for participants. This follow-up study subsequently found that two years after the MTT, bacterial diversity persisted and both GI and ASD symptoms remained “improved” compared to baseline according to the same GI and behavioral tests that were utilized previously.
Currently, one in 59 children in America have ASD. A great majority of individuals with neurobehavioral disorders, such as ASD, also experience chronic gastrointestinal symptoms. Established research supports the notion that ASD children have distinct gut microbiomes compared to neurotypical children.
This novel study highlights a non-human microbial cell perspective of neurobehavioral health, one that could help to treat conditions like ASD. The need for microbiota therapy is exigent as the study points out that currently “no medical treatment has been approved to treat core symptoms of ASD, such as social communication difficulties and repetitive behaviors”.
Submit this form and you'll receive our latest news and updates.
BMC Microbiology recently published a meta-analysis of metagenomic sequencing data from obese and non-obese participants...
Learn moreResults of a prospective and longitudinal study conducted among schoolchildren were recently published in Allergology In...
Learn moreResults of a small human clinical trial recently published in NPJ Biofilms and Microbiomes indicate that short-term use ...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment